<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03455478</url>
  </required_header>
  <id_info>
    <org_study_id>YFZX2018001</org_study_id>
    <nct_id>NCT03455478</nct_id>
  </id_info>
  <brief_title>Shanghai Eye Study for Older People</brief_title>
  <acronym>SESOP</acronym>
  <official_title>Shanghai Eye Study for Older People</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Eye Disease Prevention and Treatment Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brien Holden Vision</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Eye Disease Prevention and Treatment Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Blindness and visual impairment severely impact the visual health and life quality of people,
      particularly the 2.566 million senior citizens aged at 65 and above in Shanghai. The main
      reason is uncorrected refractive error, of which, 62.1% can be solved through refractive
      correction. For this reason, the uncorrected refractive errors of 154,000 senior citizens in
      Shanghai can be taken as a priority among the public health issues to prevent blindness. Now,
      with the aim to reduce the prevalence rate of blindness and visual impairment, it is planned
      to establish a public health service mechanism in terms of refractive error screening and
      correction for the elderly by relying on Shanghai's three-level (city-district-community) eye
      diseases prevention network, using proper refractive correction technology, and moving
      related services forward to communities in order to screen, identity, and correct blindness
      and visual impairment caused by refractive errors as early as possible.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>best-corrected visual acuity (BCVA)</measure>
    <time_frame>2 years</time_frame>
    <description>the prevalence of blindness and visual impairment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cataract surgery rate</measure>
    <time_frame>2 years</time_frame>
    <description>cataract surgery rate of Shanghai older people</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cataract surgery coverage rate</measure>
    <time_frame>2 years</time_frame>
    <description>cataract surgery coverage rate of Shanghai cataract patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>visual impairment caused by high myopia</measure>
    <time_frame>2 years</time_frame>
    <description>observing the rate of visual impairment caused by high myopia</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000000</enrollment>
  <condition>Blindness,Visual Impairment, Refractive Error, Cataract, High Myopia, Aging</condition>
  <arm_group>
    <arm_group_label>corrected refractive error</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>uncorrected refractive error</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>spectacles</intervention_name>
    <description>dispending spectacles for uncorrected refractive error</description>
    <arm_group_label>corrected refractive error</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  shanghai residents with age over than 60 years old

        Exclusion Criteria:

          -  cognitive disorders; non-shanghai residents; â‰¤ 60 years old;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xun Xu, MD</last_name>
    <phone>8613386259538</phone>
    <email>drxuxun@tom.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Eye Disease Prevention &amp; Treatment Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xun Xu, MD</last_name>
      <phone>86-13386259538</phone>
      <email>drxuxun@tom.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2018</study_first_submitted>
  <study_first_submitted_qc>February 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2018</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Refractive Errors</mesh_term>
    <mesh_term>Vision Disorders</mesh_term>
    <mesh_term>Vision, Low</mesh_term>
    <mesh_term>Blindness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

